Annual Drug Patent Expirations for NEXTSTELLIS
Nextstellis is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
NEXTSTELLIS drug price trends.
This drug has one hundred and thirty-four patent family members in forty-four countries.
The generic ingredient in NEXTSTELLIS is drospirenone; estetrol. One supplier is listed for this compound. Additional details are available on the drospirenone; estetrol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
